Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-01-04 @ 8:59 AM
Study NCT ID:
NCT03149250
Status:
UNKNOWN
Last Update Posted:
2017-08-22
First Post:
2017-05-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia
Sponsor:
Goethe University
Organization:
Study Overview
Official Title:
Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia - a Cross-sectional Study
Status:
UNKNOWN
Status Verified Date:
2017-08
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study aims to investigate the impact of preeclampsia on hemostasis.
Detailed Description:
In comparison to healthy pregnant women and non-pregnant woman, this study analyses parameters of primary hemostasis and plasmatic coaguation in preeclamptic pregnant woman. Detailed analyses of the platelet function is performed using the Multiple Electrode Aggregometry, detailed analyses of the plasmatic coagulation syste is performed by isolated coaguation factor analyses and conventional coagulation analyses.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: